Cardinal Health, Inc. (CAH)

Healthcare
Medical Distribution
United States
Yahoo Finance  •  Trading View  •  Company site
Price
$155.67
▲ 1.48 (0.96%)
Market Cap
$36,984,496,128
Shares: 241,000,000
P/E
25.94
P/B: -14.56
ROE
-56.13%
Current Ratio: 0.94
Fundamentals Score
66 (NEUTRAL)

Company Overview

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Headquarters: 7000 Cardinal Place, Dublin, OH, 43017, United States  |  Employees: 53084  |  Website: cardinalhealth.com
Key Contacts
IR / Phone: 614 757 5000
Exchange: NYQ
Industry: Medical Distribution
Quick Financial Snapshot
Revenue$222,578,000,000
Net Income$1,561,000,000
Free Cash Flow$1,850,000,000
Book Value / Share$-10.93

Balance Sheet & Liquidity

Total Liabilities$55,756,000,000
Total Equity$-2,781,000,000
Debt / Equity-3.07
Current Ratio0.94
Interest Coverage10.58
Working Capital$-2,524,000,000

Valuation Metrics

Core multiples and valuation signals — useful to compare vs peers.

P/E (TTM)25.94
Industry P/EN/A
Forward P/E18.02
P/B-14.56
Price / Sales0.18
P / FCF21.89
EV / EBITDA14.53
Graham NumberN/A
DCF (placeholder)
Notes: red items typically indicate expensive multiples relative to fundamentals. Use the "Compare with industry" tool for context.

EPS (Annual)

Financial Performance

Revenue vs Net Income

Free Cash Flow (annual)

Profitability & Efficiency

Gross Margin 3.67%
Operating Margin 1.02%
Net Margin 0.70%
ROIC 11.50%
Asset Turnover 4.19

Automated Fundamental Signals (Score: 66)

Passed
  • EPS shows upward trend
  • EPS CAGR 32.70%
  • Price CAGR 5.72%
  • ROIC 11.5%
  • P/FCF 21.89
  • P/B Ratio -14.56
  • Positive Free Cash Flow
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
Failed
  • Gross Margin 3.7%
  • Operating Margin 1.0%
  • CapEx intensity
  • Low reliance on intangibles
  • DCF valuation (Fairly valued)

Price Chart (Candlestick)

Technical Analysis (Score: 75)

RSI (14)53.51
SMA 50152.05
SMA 200144.05
MACD1.10
Signal BULLISH
RSI 53.5, SMA trend bullish, momentum 39.1%.

Governance & Management

Governance scores: Audit: 10 | Board: 1 | Compensation: 4 | Shareholder Rights: 1
Executive Team
NameTitle
Mr. Jason M. Hollar CEO & Director (1973)
Mr. Aaron E. Alt J.D. Chief Financial Officer (1972)
Ms. Jessica L. Mayer Chief Legal & Compliance Officer (1969)
Mr. Stephen M. Mason Chief Executive Officer of GMPD segment (1971)
Ms. Deborah L. Weitzman Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment (1965)
Ms. Mary C. Scherer Senior VP & Chief Accounting Officer (—)
Matt Sims Vice President of Investor Relations (—)
Ms. Ola M. Snow Chief Human Resources Officer (1968)
Governance data last updated: 10/1/2025

Latest News

No news available for this company.

← Back